Litigation Details for Patheon Softgels Inc. v. Apotex Inc. (D. Del. 2018)
✉ Email this page to a colleague
Patheon Softgels Inc. v. Apotex Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-01-02 |
| Court | District Court, D. Delaware | Date Terminated | 2018-03-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
| Jury Demand | None | Referred To | Mary Pat Thynge |
| Patents | 9,693,978; 9,693,979 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Patheon Softgels Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Patheon Softgels Inc. v. Apotex Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-01-01 | 1 | United States Patent Nos. 9,693,978 (the “’978 patent”) and 9,693,979 (the “’979 patent”) (collectively… Infringement of U.S. Patent No. 9,693,978 by Apotex Under…Declaratory Judgment of Infringement of U.S. Patent No. 9,693,978 by Apotex 40. Plaintiffs…collectively, the “Patents-in- suit”) under the patent laws of the United States, 35 U.S.C. §100, et seq. This… THE PATENTS-IN-SUIT 7. On July 4, 2017, the United States Patent and Trademark | External link to document | |
| 2018-01-01 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,693,978 B2; US 9,693,979 …2018 20 March 2018 1:18-cv-00003 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
